These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 15860477)
1. Apolipoprotein epsilon4 allele and problems with orientation are associated with a persistent decline in cognition in community-dwelling elderly persons. Wayne SJ; Vellas BJ; Brodie SG; Garry PJ; Baumgartner RN J Gerontol A Biol Sci Med Sci; 2005 Mar; 60(3):375-9. PubMed ID: 15860477 [TBL] [Abstract][Full Text] [Related]
2. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population. Qiu C; Winblad B; Fratiglioni L Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218 [TBL] [Abstract][Full Text] [Related]
3. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Jonker C; Schmand B; Lindeboom J; Havekes LM; Launer LJ Arch Neurol; 1998 Aug; 55(8):1065-9. PubMed ID: 9708956 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein e genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians. Bathum L; Christiansen L; Jeune B; Vaupel J; McGue M; Christensen K J Am Geriatr Soc; 2006 Apr; 54(4):654-8. PubMed ID: 16686878 [TBL] [Abstract][Full Text] [Related]
5. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600 [TBL] [Abstract][Full Text] [Related]
6. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910 [TBL] [Abstract][Full Text] [Related]
7. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia. Lavretsky H; Ercoli L; Siddarth P; Bookheimer S; Miller K; Small G Am J Geriatr Psychiatry; 2003; 11(6):667-73. PubMed ID: 14609807 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Yaffe K; Cauley J; Sands L; Browner W Arch Neurol; 1997 Sep; 54(9):1110-4. PubMed ID: 9311354 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. Yip AG; Brayne C; Easton D; Rubinsztein DC; J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106 [TBL] [Abstract][Full Text] [Related]
11. APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies. Niti M; Yap KB; Kua EH; Ng TP J Gerontol A Biol Sci Med Sci; 2009 Feb; 64(2):306-11. PubMed ID: 19181718 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study. Winnock M; Letenneur L; Jacqmin-Gadda H; Dallongeville J; Amouyel P; Dartigues JF J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):794-7. PubMed ID: 12023428 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study. Beker N; Sikkes SAM; Hulsman M; Tesi N; van der Lee SJ; Scheltens P; Holstege H JAMA Netw Open; 2020 Feb; 3(2):e200094. PubMed ID: 32101309 [TBL] [Abstract][Full Text] [Related]
14. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Juva K; Verkkoniemi A; Viramo P; Polvikoski T; Kainulainen K; Kontula K; Sulkava R Neurology; 2000 Jan; 54(2):412-5. PubMed ID: 10668704 [TBL] [Abstract][Full Text] [Related]
15. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396 [TBL] [Abstract][Full Text] [Related]
16. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. Carmelli D; DeCarli C; Swan GE; Kelly-Hayes M; Wolf PA; Reed T; Guralnik JM J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):M103-9. PubMed ID: 10737693 [TBL] [Abstract][Full Text] [Related]
17. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study. Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354 [TBL] [Abstract][Full Text] [Related]
18. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Graves AB; Bowen JD; Rajaram L; McCormick WC; McCurry SM; Schellenberg GD; Larson EB Neurology; 1999 Oct; 53(7):1480-7. PubMed ID: 10534255 [TBL] [Abstract][Full Text] [Related]
19. Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging. Hu P; Bretsky P; Crimmins EM; Guralnik JM; Reuben DB; Seeman TE J Gerontol A Biol Sci Med Sci; 2006 Jun; 61(6):616-20. PubMed ID: 16799145 [TBL] [Abstract][Full Text] [Related]